Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease: a case-control study.
Fiche publication
Date publication
décembre 2022
Journal
Infection prevention in practice
Auteurs
Membres identifiés du Cancéropôle Est :
Dr VUITTON Lucine
Tous les auteurs :
Amiot A, Bourrier A, Gornet JM, Dewit O, Nancey S, Altwegg R, Abitbol V, Laharie D, Reenaers C, Gagnière C, Buisson A, Nachury M, Viennot S, Vuitton L, Stefanescu C, Marteau P, Bouguen G, Seksik P,
Lien Pubmed
Résumé
Whether healthcare workers with inflammatory bowel disease (IBD) are at increased risk of Novel coronavirus disease (COVID-19) due to occupational exposure is unknown.
Mots clés
COVID-19, Novel coronavirus disease, CRP, C-reactive protein, Crohn's disease, Healthcare worker, IBD, inflammatory bowel disease, Inflammatory bowel disease, SARS-CoV-2, SARS-CoV-2, severe acute respiratory syndrome coronavirus 2, TNF, tumor necrosis factor-alpha, UC, ulcerative colitis, Ulcerative colitis
Référence
Infect Prev Pract. 2022 12 30;:100267